Abstract
α-Chloralose is widely used as an anesthetic in the laboratory due to its minimal effects on autonomic and cardiovascular systems, yet little is known about its mechanism of action. We examined the effects of α-chloralose on γ-aminobutyric acid type A (GABAA) receptor activity because recent studies have shown that several classes of general anesthetics modulate the function of this receptor. GABAA receptor activity was assayed by measuring the GABA-induced current in Xenopus oocytes expressed with human GABAA receptor alpha-1,beta-1 and gamma-2L subunits. α-Chloralose produced a concentration-dependent potentiation of the GABA-induced current with an EC50 value of 49 μM and a maximal effect of 239% of control. Membrane current was not affected by α-chloralose in the absence of GABA. α-Chloralose (100 μM) increased the affinity for GABA 5-fold and produced a small (17%) increase in the efficacy of GABA. Measurement of the reversal potentials for the α-chloralose response suggested that the effect is mediated through increased Cl− conductance. Studies of α-chloralose interactions with other allosteric modulators determined that α-chloralose binds to a site on the GABAA receptor complex distinct from the benzodiazepine, neurosteroid and barbiturate sites. Chloral hydrate, trichloroethanol and urethane also augmented GABA-induced currents. α-Chloralose had no effect on the hydroxytryptamine-induced currents in oocytes expressed with the 5-hydroxytryptamine3 receptor. These data extend the number of classes of anesthetics that allosterically modulate GABAA receptor activity and indicate that GABAAreceptors may be a common site of action for diverse classes of general anesthetics.
Footnotes
-
Send reprint requests to: Dr. Kennon M. Garrett, Department of Physiology, University of Oklahoma Health Sciences Center, P.O. Box 26901, Oklahoma City, OK 73190. E-mail:kennon-garrett{at}ouhsc.edu
-
↵1 This work was supported by the Oklahoma Center for the Advancement of Science and Technology.
- Abbreviations:
- GABA
- γ-aminobutyric acid
- ANOVA
- analysis of variance
- 3α-OH-DHP
- 3α-hydroxy-5α-pregnan-20-one
- 3β-OH-DHP
- 3β-hydroxy-5α-pregnan-20-one
- DMSO
- dimethylsulfoxide
- HEPES
- N-2-hydroxyethyl-piperazine-N′-2-ethanesulfonic acid
- 5-HT
- 5-hydroxytryptamine
- Received September 3, 1997.
- Accepted January 23, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|